138 related articles for article (PubMed ID: 33155529)
1. Weak spots inhibition in the
Adewumi AT; Elrashedy A; Soremekun OS; Ajadi MB; Soliman MES
J Biomol Struct Dyn; 2022 Apr; 40(7):2934-2954. PubMed ID: 33155529
[No Abstract] [Full Text] [Related]
2. Cyclipostins and cyclophostin analogs inhibit the antigen 85C from
Viljoen A; Richard M; Nguyen PC; Fourquet P; Camoin L; Paudal RR; Gnawali GR; Spilling CD; Cavalier JF; Canaan S; Blaise M; Kremer L
J Biol Chem; 2018 Feb; 293(8):2755-2769. PubMed ID: 29301937
[TBL] [Abstract][Full Text] [Related]
3. Exploring Covalent Allosteric Inhibition of Antigen 85C from Mycobacterium tuberculosis by Ebselen Derivatives.
Goins CM; Dajnowicz S; Thanna S; Sucheck SJ; Parks JM; Ronning DR
ACS Infect Dis; 2017 May; 3(5):378-387. PubMed ID: 28285521
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and X-ray analysis of a glycoconjugate bound to Mycobacterium tuberculosis antigen 85C.
Ibrahim DA; Boucau J; Lajiness DH; Veleti SK; Trabbic KR; Adams SS; Ronning DR; Sucheck SJ
Bioconjug Chem; 2012 Dec; 23(12):2403-16. PubMed ID: 23190459
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and biological evaluation of sugar-derived esters, alpha-ketoesters and alpha-ketoamides as inhibitors for Mycobacterium tuberculosis antigen 85C.
Sanki AK; Boucau J; Umesiri FE; Ronning DR; Sucheck SJ
Mol Biosyst; 2009 Sep; 5(9):945-56. PubMed ID: 19668859
[TBL] [Abstract][Full Text] [Related]
6. Identification of potent Antigen 85C inhibitors of Mycobacterium tuberculosis via in-house lichen library and binding free energy studies Part-II.
Pant R; Joshi A; Joshi T; Maiti P; Nand M; Joshi T; Pande V; Chandra S
J Mol Graph Model; 2021 Mar; 103():107822. PubMed ID: 33333421
[TBL] [Abstract][Full Text] [Related]
7. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
Tomioka H
Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
[TBL] [Abstract][Full Text] [Related]
8. Antigen 85C inhibition restricts Mycobacterium tuberculosis growth through disruption of cord factor biosynthesis.
Warrier T; Tropis M; Werngren J; Diehl A; Gengenbacher M; Schlegel B; Schade M; Oschkinat H; Daffe M; Hoffner S; Eddine AN; Kaufmann SH
Antimicrob Agents Chemother; 2012 Apr; 56(4):1735-43. PubMed ID: 22290959
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure of the secreted form of antigen 85C reveals potential targets for mycobacterial drugs and vaccines.
Ronning DR; Klabunde T; Besra GS; Vissa VD; Belisle JT; Sacchettini JC
Nat Struct Biol; 2000 Feb; 7(2):141-6. PubMed ID: 10655617
[TBL] [Abstract][Full Text] [Related]
10. Identification of potential Mycolyltransferase Ag85C inhibitors of Mycobacterium tuberculosis H37Rv via Virtual High Throughput Screening and Binding free energy studies.
Pant R; Joshi A; Maiti P; Nand M; Pande V; Chandra S
J Mol Graph Model; 2020 Jul; 98():107584. PubMed ID: 32200279
[TBL] [Abstract][Full Text] [Related]
11. An integrated computational approach of molecular dynamics simulations, receptor binding studies and pharmacophore mapping analysis in search of potent inhibitors against tuberculosis.
Agarwal S; Verma E; Kumar V; Lall N; Sau S; Iyer AK; Kashaw SK
J Mol Graph Model; 2018 Aug; 83():17-32. PubMed ID: 29753941
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of the Mycobacterium tuberculosis antigen 85 complex by covalent, allosteric inhibitors.
Favrot L; Lajiness DH; Ronning DR
J Biol Chem; 2014 Sep; 289(36):25031-40. PubMed ID: 25028518
[TBL] [Abstract][Full Text] [Related]
13. Mycolyltransferase from
Goins CM; Dajnowicz S; Smith MD; Parks JM; Ronning DR
J Biol Chem; 2018 Mar; 293(10):3651-3662. PubMed ID: 29352107
[No Abstract] [Full Text] [Related]
14. Drug targeted virtual screening and molecular dynamics of LipU protein of Mycobacterium tuberculosis and Mycobacterium leprae.
Kaur G; Pandey B; Kumar A; Garewal N; Grover A; Kaur J
J Biomol Struct Dyn; 2019 Mar; 37(5):1254-1269. PubMed ID: 29557724
[TBL] [Abstract][Full Text] [Related]
15. Identification of new benzamide inhibitor against α-subunit of tryptophan synthase from Mycobacterium tuberculosis through structure-based virtual screening, anti-tuberculosis activity and molecular dynamics simulations.
Naz S; Farooq U; Ali S; Sarwar R; Khan S; Abagyan R
J Biomol Struct Dyn; 2019 Mar; 37(4):1043-1053. PubMed ID: 29502488
[TBL] [Abstract][Full Text] [Related]
16. Resisting resistant Mycobacterium tuberculosis naturally: mechanistic insights into the inhibition of the parasite's sole signal peptidase Leader peptidase B.
Dhiman H; Dhanjal JK; Sharma S; Chacko S; Grover S; Grover A
Biochem Biophys Res Commun; 2013 Apr; 433(4):552-7. PubMed ID: 23510997
[TBL] [Abstract][Full Text] [Related]
17. Functional insights from a comparative study on the dynamics of Antigen85 proteins and MPT51 from Mycobacterium tuberculosis.
Sundar S; Annaraj D; Selvan A; Biswas PG; Vijayakumaran R; Anishetty S
J Mol Model; 2015 Dec; 21(12):310. PubMed ID: 26564147
[TBL] [Abstract][Full Text] [Related]
18. Mapping of murine Th1 helper T-Cell epitopes of mycolyl transferases Ag85A, Ag85B, and Ag85C from Mycobacterium tuberculosis.
D'Souza S; Rosseels V; Romano M; Tanghe A; Denis O; Jurion F; Castiglione N; Vanonckelen A; Palfliet K; Huygen K
Infect Immun; 2003 Jan; 71(1):483-93. PubMed ID: 12496199
[TBL] [Abstract][Full Text] [Related]
19. Increasing the structural coverage of tuberculosis drug targets.
Baugh L; Phan I; Begley DW; Clifton MC; Armour B; Dranow DM; Taylor BM; Muruthi MM; Abendroth J; Fairman JW; Fox D; Dieterich SH; Staker BL; Gardberg AS; Choi R; Hewitt SN; Napuli AJ; Myers J; Barrett LK; Zhang Y; Ferrell M; Mundt E; Thompkins K; Tran N; Lyons-Abbott S; Abramov A; Sekar A; Serbzhinskiy D; Lorimer D; Buchko GW; Stacy R; Stewart LJ; Edwards TE; Van Voorhis WC; Myler PJ
Tuberculosis (Edinb); 2015 Mar; 95(2):142-8. PubMed ID: 25613812
[TBL] [Abstract][Full Text] [Related]
20. Design of novel quinoline-aminopiperidine derivatives as
Wang J; Zhao C; Tu J; Yang H; Zhang X; Lv W; Zhai H
J Biomol Struct Dyn; 2019 Jul; 37(11):2913-2925. PubMed ID: 30044186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
